Sinolytics.Radar: China's biopharma industry achieves commercial breakthrough

China’s biopharma industry is experiencing a commercial breakthrough. Driven by robust government policies and rapidly growing global licensing deals, Chinese innovative drugs are no longer just following global trends—they’re setting them.

Letzte Aktualisierung: 24. Juli 2025